|Seattle Genetics Announces Pricing of Public Offering of Common Stock|
A shelf registration statement relating to the shares was previously
filed with and became effective by rule of the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward Looking Statements
Certain of the statements made in this press release are forward
looking, such as those, among others, relating to Seattle Genetics’
expectations regarding the completion, timing and size of the public
offering, and its anticipated use of net proceeds from the offering.
Actual results or developments may differ materially from those
projected or implied in these forward-looking statements. Factors that
may cause such a difference include risks and uncertainties related to
completion of the public offering on the anticipated terms or at all,
market conditions, the satisfaction of customary closing conditions
related to the public offering, and the acquisition of